SymBio PharmaceuticalsSYMQY -12.42%35 Days Inventory is 343.03 as of Dec. 2025, which is 369% above its 10-year median of 73.09. GuruFocus rates SYMQY with a GF Score™ of 35/100 and a GF Value™ of $0.48. The stock has 6 warning signs investors should review. Among 923 Drug Manufacturers companies, SymBio Pharmaceuticals ranks worse than 79.41% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
SymBio Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.27.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
SymBio Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 0.95.
SymBio Pharmaceuticals (OTCPK:SYMQY) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
SymBio Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
SymBio Pharmaceuticals's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
SymBio Pharmaceuticals Days Inventory Related Terms
SymBio Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for SymBio Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SymBio Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SymBio Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SymBio Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where SymBio Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SymBio Pharmaceuticals (SYMQY) has a Days Inventory of 343.03 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on SymBio Pharmaceuticals and its competitors. This is 369% above median its historical median of 73.09. Over the past decade, SymBio Pharmaceuticals' Days Inventory has ranged from 48.14 to 271.10. According to the industry distribution chart, SymBio Pharmaceuticals ranks #733 out of 923 companies in the Drug Manufacturers industry, placing it in the top 79.4%.
Is SymBio Pharmaceuticals' Days Inventory too high?
SymBio Pharmaceuticals' current Days Inventory of 343.03 is 369% above median its 10-year median of 73.09. Over the past 10 years, this metric has ranged from a low of 48.14 to a high of 271.10. The Drug Manufacturers industry median Days Inventory is 164.48. SymBio Pharmaceuticals' value of 343.03 is 108.6% above this industry median. Based on the distribution chart, SymBio Pharmaceuticals ranks #733 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, SymBio Pharmaceuticals has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does SymBio Pharmaceuticals' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, SymBio Pharmaceuticals ranks #733 out of 923 companies for Days Inventory. This places SymBio Pharmaceuticals in the lower half of its industry. The industry median Days Inventory is 164.48. SymBio Pharmaceuticals' value of 343.03 is 108.6% above this benchmark. Historically, SymBio Pharmaceuticals' own Days Inventory has ranged from 48.14 to 271.10 over the past decade. While the company's 10-year median is 73.09 vs. the industry median of 164.48, SymBio Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SymBio Pharmaceuticals's current Days Inventory of 343.03 is 108.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on SymBio Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SymBio Pharmaceuticals's current Days Inventory is 343.03, which is 369% above median its own 10-year median of 73.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SymBio Pharmaceuticals stock overvalued right now?
SymBio Pharmaceuticals (SYMQY) has a current Days Inventory of 343.03. The stock's GF Value™ is $0.48, compared to a current price of $0.56 — trading 16.2% above its estimated fair value. The current Days Inventory is 343.03, which is 369% above median its 10-year median of 73.09 and 108.6% above the Drug Manufacturers industry median of 164.48. SymBio Pharmaceuticals' overall GF Score™ is 35/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For SymBio Pharmaceuticals (SYMQY), the current Days Inventory is 343.03 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SymBio Pharmaceuticals (SYMQY) Overvalued in 2026?
Based on GuruFocus' analysis, SymBio Pharmaceuticals stock appears to be overvalued.
The current stock price of $0.56 is trading 16.2% above its estimated GF Value™ of $0.48.
Key valuation signals for SYMQY:
Days Inventory: 343.03 (369% above median its 10-year median of 73.09)
GF Value™: $0.48 vs. price of $0.56 (16.2% above fair value)
Industry Position: 108.6% above the Drug Manufacturers median (#733 of 923)
No single metric tells the full story. See the SYMQY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in development of new drugs with a primary focus on the treatment of rare diseases, mainly in the areas of oncology, hematology and multiple viral infections, and conduct integrated business activities that encompass search for new drug candidates, development, manufacturing, and sales.
35GF Score
Get the complete analysis for SYMQY
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SYMQY has been successfully added to your 
